Highlights and Quick Summary
- Selling, General and Administrative Expense of Revenue for the quarter ending September 30, 2022 was 138.08% (a -4.44% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative Expense of Revenue increased by 296.78%
- Annual Selling, General and Administrative Expense of Revenue for 2021 was 110.37% (a -99.91% decrease from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2020 was 123354.17% (a 8.03% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2019 was 114183.33% (a Infinity% increase from previous year)
- Twelve month Selling, General and Administrative Expense of Revenue ending September 30, 2022 was 90.15% (a -9.78% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative Expense of Revenue decreased by -18.32% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 90.15% | 99.92% | 109.83% | 110.37% |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative Expense of Revenue of Beam Therapeutics Inc.
Most recent Selling, General and Administrative Expense of Revenueof BEAM including historical data for past 10 years.Interactive Chart of Selling, General and Administrative Expense of Revenue of Beam Therapeutics Inc.
Beam Therapeutics Inc. Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 138.08% | 144.5% | 228.26% | – |
| 2021 | 34.8% | 2067.37% | 223383.33% | 171216.67% | 110.37% |
| 2020 | 139233.33% | 125033.33% | 115616.67% | 113533.33% | 123354.17% |
| 2019 | 102666.67% | 91450.0% | 82950.0% | 0.0% | 114183.33% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology